Advances making way for 2024 Cold Chain Packaging Solutions
As per the recent projections, the market when it comes to temperature-controlled packaging solutions is most likely to reach almost $26.2 billion by 2030,...
Innovation-First Mindset: Key To Drive Advanced Therapies
The Advanced Therapies Treatment Centre- ATTC Network has gone on to release a report that stresses the pressing need when it comes to swift...
Factors Influencing Current APAC Biopharma & Healthcare
In the last five years, there have been various local governments in the Asia-Pacific region that have enacted beneficial policies and also regulatory frameworks...
10 Benefits of Digital Transformation In Pharma Production
In the healthcare industry, both patients as well as caregivers share a common desire for the best possible outcome. Technology makes it much easier...
Deciphering The Impact of EU HTA On Emerging Biopharma
What is the Joint European HTA?
Navigating pricing and reimbursement in the European Union (EU) can be a complex task for emerging biopharmaceutical companies (EBPs),...
Enhancing Medication Security Through Pharma Traceability
The pharmaceutical sector, due to its importance in human health, is subject to rigorous global regulations. Pharmaceutical traceability, commonly known in the industry as...
The Impact of DSCSA EDDS Guidance On Pharmaceutical Industry
The HDA Traceability Seminar commenced with a full audience and a prevailing message woven into the presentations: The FDA's release of the DSCSA EDDS...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...























